Theolytics is a biotech company working to develop curative cancer therapies. We are a University of Oxford spin-out, backed by Oxford Sciences Innovation (OSI), harnessing viruses to combat cancer.
A step-change in the oncolytic viral therapy field, our Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population.
Our team is one of the most important elements of who we are and what we do. We combine world leading scientific expertise – encompassing virology, cancer biology, immunology, bioinformatics, and molecular biology – with a track record of translating oncolytic viral therapies into the clinic.
If you think your principles are aligned with ours, we want to hear from you!
Please apply by sending your CV and Covering letter to email@example.com.